b Tested in sodium chloride 0.9%.
c Tested in Ringer’s injection, lactated.
d Test performed using the formulation WITHOUT edetate disodium.
e Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
f Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.
g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
h Tested in dextrose 5% in Ringer’s injection, lactated.
i Tested in sodium chloride 0.45%.
j Lyophilized formulation tested.
k Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.
l Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
m Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.
n Not specified whether concentration refers to single component or combined components.
o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
p Tested in both dextrose 5% and sodium chloride 0.9%.
q Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
r Test performed using the formulation WITH edetate disodium.